By Nigam Arora & Dr. Natasha Arora
Signal Limited is a Signal(s) with a great record in similar situations but does not meet all of the stringent criteria for a Signal. Typically Signal Limited has higher risk-reward compared to a Signal over the short term.
C3.AI (AI) specializes in enterprise software to use artificial intelligence. AI has announced that it will use generative AI tools including ChatGPT in its tools. Specifically, AI will use generative bots for enterprise search.
Hype
Right now AI stock is being overhyped. It has jumped on the announcement that it will use ChatGPT.
AI has significant competition. If the past is an indication, the hype will die down causing the stock to pullback. The stock should be bought only on a pullback.
Zones
For those following the Good Way, the Buy Now rating is 🔒 (To see the locked content, please take a 30 day free trial),
For those following the Best Way, the buy zone is 🔒. AI is trading at $20.50 as of this writing. The maximum recommended position size is 🔒 of full core position size. Investors should consider this as a speculative stock and as such, this is suitable only for aggressive investors.
Please read the section titled Speculative Positions in Trade Management Guidelines to learn about speculative positions.
The first target zone is 🔒. If there is a fill in the buy zone, the plan will be to take partial profits in the first target zone and raise the stop on the remaining to protect profits.
In an uber-hype situation, the second target zone is 🔒.
Keep in mind that the fair value of the stock is under 🔒. This is mostly a play on the momentum and hype. For this reason, this is only a trade and not an investment.
The stop zone is 🔒.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
